Sinnamon Park Vet Sees Increase in Tick Poisoning Cases as Warmer Weather Hits

Pet owners in Brisbane are being urged to stay vigilant as Dr Sureiyan Hardjo, a vet at the Animal Referral Hospital in Sinnamon Park, reports an increase in cases of tick paralysis, with several dogs requiring intensive care treatment. 



The vet noted that the clinic has been busier in recent weeks due to an uptick in paralysis tick cases. Dr Hardjo highlighted that seven pets were admitted to the Sinnamon Park facility’s intensive care unit in one week, with three requiring intubation and one placed on a ventilator. 

The previous week, two animals were also on ventilators due to severe symptoms from tick bites.

Predicting Tick Season

According to Professor Stephen Barker, a parasitologist from the University of Queensland, the severity of each tick season is closely tied to the weather. Mr Barker, who has studied paralysis ticks for over 25 years, explained that while this year is expected to have an “average” risk of tick poisoning, this still translates to thousands of vet visits. He emphasised that even an average season could be dangerous for pets, and pet owners should remain cautious.

Female paralysis ticks, known scientifically as Ixodes holocyclus, lay eggs around January depending on the weather. Mr Barker pointed out that while hot and dry conditions can reduce the number of ticks, mild and wet weather helps them survive and reach maturity, making them more likely to seek out hosts in spring and summer.

Animal Referral Hospital in Sinnamon Park,
Photo Credit: Google Maps/ARH Brisbane

Symptoms and Treatment

Paralysis ticks release toxins when they feed on their hosts, which can cause severe physiological complications, especially in dogs and cats. 

According to Dr Hardjo, common symptoms include weakness in the legs, laboured breathing, and changes in behaviour, such as lethargy or difficulty swallowing. He warned that these symptoms can quickly become life-threatening if left untreated, with some animals experiencing paralysis of vital muscles, including those used for breathing.

Mr Barker recommended checking pets regularly for ticks, especially after being outdoors. Treatment typically involves administering tick anti-serum and manually checking the animal for additional ticks. Recovery times vary, depending on the severity of the case, but pets with mild symptoms can often return home within a couple of days.



With the tick season upon them, both experts call on the community to proactively protect their pets. Dr Hardjo stressed that keeping dogs on a leash and using preventative treatments are key to avoiding serious illness.

Published 29-Sept-2024

Animal Referral Hospital in Sinnamon Park Joins Canine Anti-Cancer Drug Trial

The Animal Referral Hospital in Sinnamon Park joins four other vet clinics in a trial for a canine anti-cancer drug that could be given orally to pet dogs diagnosed with B cell lymphoma that have yet to undergo any cancer treatment.

PharmaAust, a Perth biotech company, has developed an anti-cancer drug monepantel (MPL) and the trial is now on Phase IIb. The aim of this trial is to determine the optimal prescribed doses that would guarantee a successful treatment. 



It comes after Phase IIa showed tumor regression and disease stabilisation among the participating pets. According to chief scientific officer Dr Richard Mollard, six of the seven dogs in Phase IIa had favourable outcomes with a smaller tumor after taking the drug for 14 days.

PharmaAust said that several pet owners have signed up for the trial happening across veterinary clinics like Animal Referral Hospital in Homebush (Sydney), Western Australian Veterinary Emergency and Speciality in Success (Perth), Perth Veterinary Specialists in Osborne Park (Perth) and the Veterinary Specialist Services in Underwood (Brisbane), aside from the Sinnamon Park facility. 

The company is also opening two more sites in Melbourne and Sydney.

Photo Credit: Pixabay 

There is no cure for B cell lymphoma and half of the dogs diagnosed with this disease may survive without treatment for 30 days. The other half, however, could experience their disease progressing particularly fast. Right now, chemotherapy is the only best treatment management but it could result in adverse effects and won’t guarantee a relapse. 

If Phase IIb succeeds, PharmaAust plans to conduct Phase III with a larger number of participants that will have to be screened before joining the trials.

Eventually, PharmaAust hopes that their medication may be a treatment option for pet owners with dogs with cancer.